Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7

被引:30
|
作者
Antonio, L
Xu, J
Little, JM
Burchell, B
Magdalou, J
Radominska-Pandya, A
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Henri Poincare Nancy 1, CNRS, UMR 7561, Vandoeuvre Les Nancy, France
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
关键词
UDP-glucuronosyltransferase; human; catechols; liver; stomach; intestine;
D O I
10.1016/S0003-9861(02)00748-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The substrate specificity of human gastric and intestinal UDP-glucuronosyltransferases (UGTs) toward catechols was investigated and compared to that of liver UGTs. Small catechols were efficiently glucuronidated by stomach (0.8-10.2nmol/mg protein . min) and intestine (0.9-7.7 nmol/mg protein . min) with activities in a range similar to those found in liver (2.9-19 nmol/mg protein . min). Large interindividual variations were observed among the samples. Immunoblot analysis demonstrated the presence of UGT1A6 and UGT2B7 in stomach and throughout the intestine. Recombinant human UGT1A6, 1A9, and 2B7, stably expressed in mammalian cells, all effectively catalyzed catechol glucuronidation. K-m values (0.09-13.6 mM) indicated low affinity for UGTs and V-max values ranged from 0.51 to 64.0 nmol/mg protein . min. These results demonstrate for the first time glucuronidation of catechols by gastric and intestinal microsomal UGTs and three human recombinant UGT isoforms. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:251 / 261
页数:11
相关论文
共 50 条
  • [31] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver
    J Ramírez
    S Mirkov
    W Zhang
    P Chen
    S Das
    W Liu
    M J Ratain
    F Innocenti
    The Pharmacogenomics Journal, 2008, 8 : 152 - 161
  • [32] Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5phenylhydantoin by human UDP-Glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: Effects of UGT-UGT interactions
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Fujiwara, Ryoichi
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (09) : 1679 - 1686
  • [33] Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen
    Wang, Haina
    Yuan, Lingmin
    Zeng, Su
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (11) : 1757 - 1763
  • [34] Glucuronidation of arachidonic acid, 20-hydroxy-eicosatetraenoic acid and prostaglandin E2 by human hepatic and intestinal UDP-glucuronosyltransferases and recombinant UGT2B7
    Sonka, J
    Little, J
    Samokyszyn, V
    Radominska-Pandya, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 194 - 194
  • [35] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver.
    Mirkov, S.
    Ramirez, J.
    Zhang, W.
    Chen, P.
    Das, S.
    Liu, W.
    Ratain, M. J.
    Innocenti, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S61 - S61
  • [36] TCDD-inducible UDP-glucuronosyltranferases (UGT1A6 and UGT1A6) in human cells
    Lehmköster, T
    Heel, H
    Münzel, P
    Bock, KW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R134 - R134
  • [37] Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9
    Kishi, Naoki
    Takasuka, Akane
    Kokawa, Yuki
    Isobe, Takashi
    Taguchi, Maho
    Shigeyama, Masato
    Murata, Mikio
    Suno, Manabu
    Hanioka, Nobumitsu
    XENOBIOTICA, 2016, 46 (04) : 289 - 295
  • [38] Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7
    Wu, Zhufeng
    Liu, Hongming
    Wu, Baojian
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2015, 67 (04) : 583 - 596
  • [39] UGT1A1 and UGT1A9 variants affect thyroxine glucuronidation in human livers.
    Graber, AY
    Innocenti, F
    Ramirez, J
    Chen, PX
    Das, S
    Ratain, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P73 - P73
  • [40] Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3
    Huang, YH
    Galijatovic, A
    Nguyen, N
    Geske, D
    Beaton, D
    Green, J
    Green, M
    Peters, WH
    Tukey, RH
    PHARMACOGENETICS, 2002, 12 (04): : 287 - 297